WASHINGTON, D.C. --- Congressman Leonard Lance (NJ-07) today announced the White House Internship Program application is now open. The application portal will remain open until 11:59PM EDT on June 16, 2017. Any applications received after the deadline will not be considered.
The Fall 2017 White House Internship Program term runs from September 6 to December 8, 2017. All applicants must be at least 18 years of age by the Internship Program start date, and must be able to commit to the full internship term to be eligible. Additionally, applicants must be U.S. citizens and meet at least one of the following criteria to apply:
The White House Internship Program is highly competitive. Applicants are selected based on their demonstrated commitment to public service, leadership in the community, and commitment to the Trump Administration. Questions about the White House Internship Program application can be directed to email@example.com. More information, including details about placement in the White House Internship Program and frequently asked questions can be found on the White House website.Read More
MILBURN, N.J. --- Congressman Leonard Lance (NJ-07) today announced the Milburn Fire Department was awarded a $231,613 federal grant to procure new safety equipment. The Congressman joined Milburn Township Mayor Cheryl H. Burstein and Fire Chief Robert Echavarria in praising the firefighters with the Milburn Fire Department.
“Millburn is very deserving of this grant. We need to provide our first responders with the best possible equipment so they can keep themselves and others safe in emergency situations. All Fire Fighters need the peace-of-mind that they are working with the best tools. This grant will go toward state-of-the-art equipment which will help them continue to effectively serve the community. I commend the entire Milburn governing body for being proactive and requesting these funds,” said Lance.
The funding from the Department of Homeland Security will be used to replace 34 outdated self-contained breathing apparatus, upgrade an air compressor and purchase new face pieces for each member of the fire squad.
“Our firefighters put their lives at risk to keep the Township of Milburn and surrounding community’s residents safe,” added Mayor Burstein. “These grant funds will play a critical role in modernizing the Milburn Fire Department and protecting those who protect our community every day. It is with great gratitude that we accept this grant and we thank Congressman Lance for his continued support.”
As a member of the Congressional Fire Services Caucus, the Seventh District lawmaker has voted to increase federal investments for both the FIRE and Staffing for Adequate Fire and Emergency Response (SAFER) grant programs. These programs were created by Congress to help address the significant staffing, equipment, training and health and safety needs of our Nation's First Responders.Read More
WASHINGTON, D.C. --- Congressman Leonard Lance (NJ-07) secured passage of his legislation, H.R. 2376, the Drug Diversion and Counterfeit Crackdown Act, through the Energy and Commerce Health Committee today as an amendment to the FDA Reauthorization Act. The legislation cracks down on counterfeit drugs entering the United States. Many American patients are buying and using bogus drugs disguised as reputable brands and today’s effort will increase the penalties for counterfeiters.
“Counterfeit drugs are flooding into the United States and too many Americans are falling victim to knock-offs that have infiltrated the U.S. supply chain. These counterfeit drugs contain harmful ingredients and incorrect or expired active ingredients. Cancer patients think they are taking the correct chemotherapy medicine but these fraudsters instead give the unsuspecting patient 50% of the real treatment. These criminals take the risk knowing the punishment is a minor offense in our criminal code. That needs to change. We need to strengthen the system and protect patients,” said Lance.
In the United States, for a new drug to reach the market it must proceed through a rigorous vetting process through the Food and Drug Administration (FDA). Once approved, these therapies are then marketed in U.S. Counterfeiters mimic these drugs with knock-off medications often created in third-world counties – well outside the scrutiny of the FDA and involving a host of poorly produced ingredients. The Centers for Disease Control estimates up to 30% of all drugs are counterfeit in developing countries. With little oversight, these drugs are then introduced into the U.S. placing the entire secure supply chain at risk. The Lance bill will close loopholes in the law, stiffen penalties for counterfeiters and discourages this market from growing.Read More
WASHINGTON, D.C. --- Congressman Leonard Lance (NJ-07) released the following statement on former FBI Director Robert Mueller being named special counsel for the Russia probe:
“Mr. Mueller will be an excellent addition to the Department of Justice probe already underway. He’s respected on both sides of the aisle, which should inspire bipartisan confidence in the ongoing investigation. There can be no interruption in getting to the truth. The American people deserve answers on Russia as soon as a thorough investigation can be completed.”Read More
WASHINGTON, D.C. --- Every year thousands of non-confidential reports are compiled by the Congressional Research Service (CRS) for use by Congressional offices and today U.S. Representatives Leonard Lance (NJ-07) and Mike Quigley (D-IL-05) reintroduced legislation to open those reports to the public. The Equal Access to Congressional Research Service Reports Act directs the Congressional Research Service to publish its reports on govinfo.gov – a site managed by the Government Printing Office (GPO) that will serve as a one-stop shop for public information.
“The CRS needs to be updated on how it conducts business. It’s 2017 and there are over 30,000 CRS reports the public cannot immediately access. Any student, reporter, taxpayer or interested citizen should be allowed to log online and view these reports. These reports are paid for by taxpayer funds, the taxpayers should be able to read them. And our national discourse could use as much factual, non-partisan information as possible. Let’s end the era of secrecy and open these reports,” said Lance, who is leading the House legislation.
Information compiled by the Congressional Research Service is not publically available. Since 1914, reports have only been available for request through House and Senate offices and the bipartisan lawmakers say it is time to bring CRS into the 21st century. Requesting CRS reports through House and Senate offices is often cited as a throwback to the era of patronage jobs and hard-copy reports being too long and expensive for CRS to be available to send through the mail. Good government and transparency groups and tax payer advocacy organizations support allowing these reports to be publically available and interjecting nonpartisan, factual information into public discourse. The lawmakers also want to end the “black market” of CRS reports by which connected individuals and lobbyists obtain reports from contacts on Capitol Hill but everyday Americans are not able to easily view these reports. The lawmakers determined that GPO has the experience and infrastructure in place to host government documents for use by the general public in a user friendly format that CRS does not.
Congressional Research Belongs to the Public (The New York Times)
Give public access to Congressional research reports (Lance and Quigley, The Hill)
The publicly funded reports you can’t read (Samuelson, Politico)
15 reasons CRS reports should be public (Kosar, R Street)Read More
WASHINGTON, D.C. --- Congressman Leonard Lance (NJ-07) released the following statement on the American Health Care Act:
“Like many of my colleagues I ran in support of a repealing Obamacare and replacing it with a plan that lowers premiums, drives down health-care costs, encourages competition and gives every American access to quality, affordable health insurance. I campaigned on a plan that protects those with pre-existing conditions and provides a stable transition for those forced into Obamacare at no fault of their own. And I ran on the promise of not simply repealing Obamacare and returning to the status quo but offering something better. The House-passed bill doesn’t achieve these goals.
“Additionally, important cost-saving provisions like purchase of policies across state lines, small business pooling and medical malpractice reform are absent from today’s legislation. And it has yet to be analyzed for cost and effects by the Congressional Budget Office.
“The bill faces substantial changes in the U.S. Senate, further guaranteeing that the final product will have to be a compromise between the two chambers. I remain committed to repealing and replacing Obamacare and will work with my colleagues across the Capitol to pass a better bill, one that lowers costs, improves access and increases quality of life for hard working New Jersey families.”Read More
WASHINGTON, D.C.— Congressman Leonard Lance (NJ-07) today announced he was teaming up with Congresswoman Anna Eshoo (CA-18) to re-introduce the FDA Safety Over Sequestration Act, or FDA SOS Act, which exempts Food and Drug Administration (FDA) user fees from sequestration. FDA user fees are paid entirely by companies in the industry to help speed up the approval of safe and effective drugs and devices. These funds are not taxpayers dollars and the Lance-Eshoo effort will make sure these funds keep going toward health innovation.
“Millions of Americans are counting on the medicines and devices currently in the FDA’s approval pipeline. We need this process moving and any effort to divert private funding from this effort must be stopped. FDA user fees support a system that helps keep innovations safe and effective. Too many life-saving innovations and therapies are needlessly compromised by the short-sighted decision to sequester these funds. I’m proud to again partner with Congresswoman Eshoo to prevent this from happening,” said Lance, a member of the Energy and Commerce Committee's Subcommittee on Health.
“The FDA’s user fees are 100 percent private sector dollars that are used specifically for lifesaving drugs and devices,” said Congresswoman Eshoo. “If the intent of sequestration is to limit public spending, withholding private monies is counterintuitive. Whether one agrees or disagrees with sequestration, private dollars should not be held hostage by the policy. It discourages investment in medical innovation and denies patients access to timely and lifesaving therapies. It’s critical now more than ever that we take steps to protect these private sector dollars. If Congress fails to vote on a new budget agreement, sequestration will return full force in the next fiscal year, putting these private sector dollars at risk,” said Eshoo, a member of the Energy and Commerce Committee's Subcommittee on Health.
The bipartisan team has successfully led the effort in the U.S. House in preventing sequester of FDA user fees, arguing against an Obama Administration decision to curtail the private dollars. Lance and Eshoo, through legislation and letter writing, have made the case that since these are private funds and not public spending, budget restraints should not apply. While they have been successful in previous fiscal years, this legislation would make a fix permanent. Sequestering these funds hinders the agency’s ability to meet congressionally-mandated responsibilities while putting patient safety at risk. The user fees are industry-financed and account for roughly 35 percent of the FDA’s budget. Under sequestration, the FDA is prohibited from collecting approximately more than $1 billion over a five-year period, according to the non-partisan Congressional Budget Office (CBO). Congress has recently increased FDA user fees in addition to strengthening and improving the review process.
The legislation is supported by the HealthCare Institute of New Jersey, Medical Device Manufacturers Association, California Healthcare Institute, AdvaMed, Leukemia Lymphoma Society, Gilead, Genentech, Patient Services Inc., National Health Council, and the American Cancer Society Action Network.
“User fees are intended to ensure that FDA is equipped to evaluate new medicines and medical devices efficiently so that new treatments and cures can be delivered to patients as quickly and safely as possible. Congressman Lance is recognized for his leadership and commitment to protecting patient access to these life-saving treatments while preserving the innovation environment critical to discovering new medical advances,” said Dean J. Paranicas, President and CEO of the HealthCare Institute of New Jersey.
“We cannot have the life science sector, a major economic engine for New Jersey, challenged by these cuts. We must protect this program from the sequester and allow the FDA to fulfill its critical public health mission,” concluded Lance.Read More
WASHINGTON, D.C. --- U.S. Representatives Leonard Lance (NJ-07) and Diana DeGette (CO-01) have introduced bipartisan legislation called the Patient Experience in Research Act of 2017 (PERA) in the U.S. House of Representatives. PERA will launch a pilot project to evaluate the psychological and social distress experienced by patients participating in a clinical trial of a drug or biological product that is intended to treat a serious or life-threatening disease or condition.
“A difficult diagnosis can take its toll on a patient. Information about the patient experience, including the challenges that come with a diagnosis, is needed to help improve the clinical trial process. Many patients are counting on the research and the products that are being developed in promising clinical trials. I am proud to introduce this bipartisan bill with my colleague Representative DeGette to help measure additional factors so patients and their caregivers have the best research,” said Lance, a member of the Energy and Commerce Health Subcommittee.
“I’m pleased to introduce the Patient Experience in Research Act with Congressman Lance," DeGette said. “Like all patients, people participating in clinical trials often experience psychological distress related to their conditions. The Patient Experience in Research Act will help ensure that patients stay with clinical trials by testing ways to offer support to those who need it. Robust clinical trial participation is essential to advancing biomedical research. By closing current gaps in care for patients taking part in trials, we can both improve health outcomes and enhance the clinical trial itself.”
The Cancer Support Community (CSC), an international nonprofit organization, also announced its support for the bipartisan legislation. “CSC applauds the vision and leadership to introduce this transformative bill,” said Kim Thiboldeaux, CEO of the Cancer Support Community. “Collecting information about the patient experience as a seamless and important part of clinical research will not only ensure that valuable information is shared in a new and meaningful way, intervening early on identified patient needs ensures adherence to standard of care and may improve patient outcome.”
For cancer patients, clinical trials provide access to new cutting-edge therapies; often the next generation of treatment. This can be a new drug, a combination of drugs, or a different way of using established therapies. There are clinical trials for every type of cancer.
However, according to CSC’s Access to Care in Cancer 2016: Barriers and Challenges report, over 53% of surveyed cancer patients did not receive social and emotional support services, including screening for distress as part of their cancer care. This suggests a disparity between access to medical care and access to psychosocial care. Psychosocial distress screening and support is a fundamental element of comprehensive cancer care.
Rep. Lance was honored by the CSC’s Cancer Policy Institute with the Public Policy Award for Research in 2013 for his commitment to health and cancer care issues. Rep. DeGette was one of the two original authors of the bipartisan 21st Century Cures Act, which allocated $1.8 billion in cancer research funding when it became law in December.Read More
WASHINGTON, D.C. – Congressman Leonard Lance (NJ-07) today released the following statement on an initial tax reform plan announced by the Trump Administration:
“My goals for tax reform are to unleash economic growth, create millions of new jobs and lower the rates on individuals. I am pleased the President outlined a plan today. There are parts of it I favor and there are parts of it I think need further debate and examination.
“One provision I oppose is the elimination of the state and local tax deduction. New Jersey taxpayers would lose under that plan. I will be a leading voice in negotiations for maintaining that deduction.
“It has been more than a quarter century since comprehensive tax reform was last enacted in Congress. It’s time to level the playing field for U.S. companies so they can invest in and create new American jobs and compete with rivals abroad. And it is time for hard-work to be rewarded and not punished by an outdated system.
“I am eager for this debate to start in Congress.”Read More
WASHINGTON, D.C. --- Congressman Leonard Lance (NJ-07) today participated in a roundtable discussion with over a dozen New Jersey business leaders and members of the United States Chamber of Commerce to discuss the work being done in Congress to help promote growth in the economy.
The meeting was part of an ongoing effort by the U.S. Chamber of Commerce to bring members of Congress together with business leaders to discuss how to best protect U.S. intellectual property (IP) rights. According to the Department of Commerce, IP supports more than 45 million jobs across 81 industries nationwide, accounting for almost one-third of the jobs in the U.S.
“Strong intellectual property protections lead to innovative new discoveries that fuel economic growth,” said Lance. “In New Jersey alone IP supports 1.5 million jobs and IP workers earn almost 28 percent more than their colleagues. Congress should be taking every measure possible to promote patents, trademarks and copyrights in order to encourage development across a variety of industries as we move forward in the 21st century. Today’s discussion was incredibly productive and I welcome the opportunity to continue to work with members of the New Jersey business community on IP related issues.”
Lance has a history of working on legislation to promote IP. As the Republican chairman of the Rare Disease Caucus Lance has championed the MODDERN Act, a bipartisan bill intended to encourage new innovative treatments for a variety of diseases and ailments that do not have currently have cures. The bill was a topic of discussion at today’s forum.
Health care reform, tax reform and the budget were also among the issues discussed by the group.
133 Cannon HOB
Washington, DC 20515
Congressman Leonard Lance was elected to the United States House of Representatives in November 2008 and reelected to a third term on November 6, 2012 to represent New Jersey’s 7th Congressional District.
As a result of the 2011 congressional redistricting process the 7th Congressional District now includes parts of Essex, Morris, Somerset, Union and Warren counties as well as all of Hunterdon County.
Prior to coming to Congress, Lance served as a member of the New Jersey State Senate beginning in 2002, where he represented the 23rd Legislative District. He held the position of Minority Leader of the Senate from 2004 to 2008.
Lance was sworn in as a Member of Congress on January 6, 2009 and was appointed to the House Financial Services Committee, where he worked on a wide range of issues relating to the financial services sector and the American economy.
In 2011 Congressman Leonard Lance left the House Financial Services Committee and has been appointed to the House Energy and Commerce Committee.
The Committee on Energy and Commerce has a broad legislative jurisdiction including national energy and environmental policy, health and health facilities, interstate and foreign commerce, consumer affairs and consumer protection, and travel and tourism.
As a member of the powerful committee Lance will play a greater role in protecting and growing jobs in New Jersey’s energy, life sciences and telecommunication sectors.
Before his election to the State Senate Lance served in the New Jersey General Assembly for 11 years (1991-2002), where he chaired the Budget Committee.
As a member of the State Legislature Lance led the fight against borrowing without voter approval. In 2004 he successfully sued Governor James McGreevey on the issue before the State Supreme Court and in 2008 New Jersey voters approved the “Lance Amendment” to the State Constitution, which requires all future borrowing to be approved by the voters. Lance also authored the successful effort to require funding for open space preservation and he was the prime sponsor of the measure that established funds for the New Jersey Cultural Trust.
Leonard Lance was the third generation of his family to serve in the New Jersey State Legislature, following his great-uncle, H. Kiefer Lance, and his father, Wesley L. Lance.
Lance was born in 1952 and raised in Hunterdon County, where he attended North Hunterdon Regional High School. Lance received a bachelor’s degree from Lehigh University, where he was elected to Phi Beta Kappa. He also holds a law degree from Vanderbilt University and a master’s degree from the Woodrow Wilson School of Public and International Affairs of Princeton University.
Lance served as the law clerk to the Warren County (NJ) Court in 1977 and 1978. He was assistant counsel for county and municipal matters to Governor Thomas H. Kean from 1983 to 1990. He has been a member of the New Jersey Council on the Humanities and a trustee of the Newark Museum, McCarter Theatre in Princeton and Centenary College in Hackettstown.
He is married to Heidi A. Rohrbach and they have a son, Peter Frank, a graduate of the University of Wisconsin. The Lances reside in Clinton Township.
Terrible news coming out of the UK this evening. Prayers for the victims as we await more information on this possible terrorist incident.
I’m inspired by the advocacy of patients like Ellie who are in Washington today raising awareness for rare diseases. https://t.co/7kaKLcS4kI
Lance on special prosecutor: "no interruption in getting to the truth" by @SaveJersey https://t.co/gGgrLLSrYy
Always great to see a little New Jersey in Washington. Thank you @NJ_REALTORS for spending time with me today. https://t.co/xzzuJgnAz5